“Clinical Efficacy or Tildrakizumab in Patients With Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S4. Accessed April 25, 2026. https://skin.dermsquared.com/skin/article/view/252.